Johannes vom Berg

University of Zurich

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

Jack Rohrer

Group Leader/Full Professor

Zurich University of Applied Sciences (ZHAW)

SWITZERLAND

View details

Ana Judith Perisé-Barrios

Universidad Alfonso X el Sabio

SPAIN

View details

Daniel Alonso-Miguel

Asistant Professor

Universidad Complutense de Madrid

SPAIN

View details

Gregor Hutter

SWITZERLAND

View details

Sebastian Kobold

University Hospital

GERMANY

View details

Laura Peña

Full Professor

Universidad Complutense de Madrid

SPAIN

View details

Sabine Spath

Head of Preclinical Operations

InCephalo

SWITZERLAND

View details

Lea Huber-Hürlimann

SWITZERLAND

View details

MARIA DE LOS DOLORES PEREZ ALENZA

Full Professor

Universidad Complutense de Madrid

SPAIN

View details

María Suárez-Redondo

Universidad Complutense de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Johannes vom Berg

Research Interests

Explore related searches

Contact this professor

Articles (10)

Flycodes enable simultaneous preclinical analysis for dozens of antibodies in single cassette–dosed mice

FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma

Pilot Study of Intratumoral Immunotherapy with Cowpea Mosaic Virus Nanoparticles: Safety in Refractory Canine Oral Tumors.

Nanobody-based canine PD-L1-targeting immune checkpoint inhibitors for cancer therapy in dogs

Protein engineering to overcome limitations of key cytokines in cancer immunotherapy: Current approaches and future perspectives

Prior corticosteroid treatment alters cPBMC composition and IFNγ response to immunotherapy in canine cancer.

Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients

Exit pathways of therapeutic antibodies from the brain and retention strategies

HDR-based CRISPR/Cas9-mediated Knockout of PD-L1 in C57BL/6 Mice.

The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells.

Collaborators (10)

Jack Rohrer

Ana Judith Perisé-Barrios

Daniel Alonso-Miguel

Gregor Hutter

Sebastian Kobold

Laura Peña

Sabine Spath

Lea Huber-Hürlimann

MARIA DE LOS DOLORES PEREZ ALENZA

María Suárez-Redondo

Make your next move.